FDA Announces Stem Cell Clinic Crackdown

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb and CBER director Peter Marks on Wednesday announced enforcement efforts the agency is taking against stem cell clinics and manufacturers that put patients at risk by marketing unapproved products.

To View This Article:

Login

Subscribe To Drug Industry Daily